Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
multiple sclerosis/turse
Link salvestatakse lõikelauale
Leht 1 alates 19 tulemused
Effects of Repetitive Hyperbaric Oxygen Therapy in Patients With Acute Ischaemic Stroke
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Study Methods:
Study Population A 60 adult (aged >18 years) patients were included with a diagnosis of acute thromboembolic ischemic stroke within 48 hours after onset, according to clinical picture and imaging findings by brain computed tomography (CT) without evidence of hemorrhage, upon admission
Effect of Photobiomodulation Treatment in Individuals With Multiple Sclerosis:
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
A Controlled Comparison of Two DBS Targets for Upper Extremity Action Tremor
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Tremor is defined as rhythmic and oscillating involuntary movements of a body part. Action tremor occurs when a body part is activated, and is clinically most frequently seen in Essential (idiopathic) Tremor (ET), with an overall prevalence of 0.9 %, and of 4.6 % in people over 65 years. But it can
Treatment of Temporo-Myofascial Disorder of Muscular Origin Using Botulinum Toxin: A Prospective Study
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Introduction Temporomandibular disorders (TMD) are a group of conditions involving the temporomandibular joint (TMJ), masticatory muscles and associated structures. This broad complex of functional disorders often affects the face and jaws causing chronic pain, earaches, headaches, migraines, neck
Adrenocorticotropic Hormone (ACTH) Effects on Myelination in Subjects With MS
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
This pilot study proposal is designed to perform a chronological measurement of MWF in new contrast-enhancing lesions in subjects treated with ACTH during an acute exacerbation of MS.
The initial course of ACTH (H.P. Acthar®) will be administered as recommended in the package insert, a subcutaneous
Single Dose Administration of Alpha-1 Anti-Trypsin for the Amelioration of Organ Injury in Patients Undergoing Cardiac Surgery
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
3 Background The use of cardiopulmonary bypass (CPB) during cardiac surgery elicits generalized non-specific systemic inflammatory response syndrome (SIRS) and subsequent activation of the cytokine, complement, and coagulation-fibrinolytic cascades (1). In approximately 11% of the patients SIRS may
Endothelial Microparticles as a Biomarker for Diagnosis and Prognosis in Early Sepsis
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
In the presence of infection, normal immune and physiologic responses act in concert to eradicate pathogens. When these responses are inappropriately regulated, sepsis develops. Sepsis is characterized by systemic manifestations of infection. The diagnosis is made by identifying at least 2 of the
A Trial of Neuroprotection With ACTH in Acute Optic Neuritis
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Patients with their first episode of unilateral acute ON will be treated with either 3 days of IV methylprednisolone followed by 11 days of oral prednisone or 15 days of intramuscular or subcutaneous corticotropin (Acthar).
This is a parallel active group, randomized controlled trial in which up to
Imaging Multiple Sclerosis Lesions Using Magnevist and Gadavist
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Rationale/Goal: The use of contrast agents in magnetic resonance imaging (MRI) has been a gold standard in diagnosing multiple sclerosis (MS). One active lesion (i.e. enhanced after the injection of contrast agent) is one of the major McDonald criteria in diagnosis patients with MS and request
An Open-Label Trial of Tocilizumab in Schizophrenia
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Schizophrenia is a chronic, debilitating disorder with life-long consequences on affected individuals and families. Schizophrenia is also associated with impaired cognition or thinking, which persists despite currently available treatments, and is an important determinant of quality of life and
Evaluation of Patient Retention of Fingolimod vs. Currently Approved Disease Modifying Therapy in Patients With Relapsing Remitting Multiple Sclerosis.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
852 Patients with relapsing remitting MS will be randomized 1:1 to fingolimod or approved first line DMTs. Patients must be either treatment naive or have received treatment with only one class of treatment (interferon beta preparation or glatiramer acetate) . Patients previously treated with DMT
Body Awareness Therapy for People With Stroke
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Translocator Protein and Inflammation After Traumatic Brain Injury
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Objective:
Brain damage following traumatic injury (TBI) results from both direct (eg, mechanical injury to the brain and vasculature) and indirect mechanisms (eg, secondary mechanisms such as inflammation). While CT and MRI can help visualize the result of inflammatory processes in the brain for
Gabapentin for Prophylaxis Intrathecal Morphine-Induced Pruritus
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The study was approved by the ethic committee of Songklanagarind Hospital in Songkhla, Thailand, and was designed as a randomized, double-blind, placebo-controlled trial. All patients gave their informed consent after receiving written information of the study. Orthopedic patients were invited to
Evaluation of Blood Brain Barrier Permeability in Chronic Stroke
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Evaluation of Blood Brain Barrier Permeability in Chronic Stroke
Mordechai Lorberboym, M.D.1, Yair Lampl, M.D.2, Ronit Gilad, M.D.2.
From the Department of Nuclear Medicine1 and the department of Neurology2 of the Edith Wolfson Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel
Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus
- Töötab 55 keeles
- Taimsed ravimid, mida toetab teadus
- Maitsetaimede äratundmine pildi järgi
- Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
- Lugege oma otsinguga seotud teaduspublikatsioone
- Otsige ravimtaimi nende mõju järgi
- Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega
Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel
